Skip to content
Home▶Archive▶Vol. 9 No. 1 (2026)▶Malignant Transformation of Oral Submucous Fibrosis: Risk…
Academia Journal of Medicine
Print ISSN 2663-8282 · Online ISSN 2663-8290
Research Article

Malignant Transformation of Oral Submucous Fibrosis: Risk Factors and Biomarkers – A Comprehensive Review

, , , , ,
Arif Awati — Assistant Professor, Department of Oral Medicine and Radiology, Al-Ameen Dental College and Hospital, Bijapur, Karnataka, India
Subho Arpan — Consultant Oral and Maxillofacial Surgeon, Rotary Club of Purulia Service Centre - Eye and Multispeciality Hospital, Purulia, West Bengal, India
Rajeev Pareek — Consultant Histopathologist, HCG Cancer Centre, Jaipur, Rajasthan, India
Prachi Kapade — Assistant Professor, Department of Oral Pathology and Microbiology, MGV’s KBH Dental College and Hospital, Nashik, Maharashtra, India
Sulabha A N — Professor and Head, Department of Oral Medicine and Radiology, Al-Ameen Dental College and Hospital, Bijapur, Karnataka, India
Smriti Choradia — Additional Professor, Department of Oral and Maxillofacial Surgery, Nair Hospital Dental College, Mumbai, Maharashtra, India
Published 28 Mar 2026 Vol. 9 No. 1 (2026), pp. 129-135 ● Open access
Formats:PDF ● Open access
Download PDF

Abstract

Oral submucous fibrosis (OSMF) is a chronic, progressive, potentially malignant disorder  predominantly associated with areca nut consumption. It is characterized by fibrosis of  the oral mucosa, leading to restricted mouth opening and increased risk of malignant  transformation into oral squamous cell carcinoma (OSCC). The rate of malignant  transformation varies widely, emphasizing the need for early identification of high-risk  individuals. This review aims to summarize the key risk factors and emerging biomarkers  associated with malignant transformation in OSMF. Major risk factors include prolonged  areca nut use, tobacco consumption, genetic susceptibility, nutritional deficiencies, and  chronic inflammation. Recent advances have highlighted the role of molecular biomarkers  such as p53, Ki-67, cyclin D1, and various salivary and serum markers in predicting malignant  potential. Understanding these factors is crucial for early diagnosis, risk stratification, and  timely intervention. The integration of clinical assessment with molecular diagnostics may  improve patient outcomes and reduce the burden of oral cancer. 

 

KeywordsOral submucous fibrosisMalignant transformationOral squamous cell carcinomaAreca nutBiomarkers

The full text of this article is available as a PDF.

Download PDF
  1. Shih, Y. H., Wang, T. H., Shieh, T. M., & Tseng, Y. H. (2019). Oral submucous fibrosis: A review on etiopathogenesis, diagnosis, and therapy. International Journal of Molecular Sciences, 20(12), 2940. https://doi.org/10.3390/ijms20122940
  2. Xu, H., Lyu, F. Y., Song, J. Y., Xu, Y. M., Jiang, E. H., Shang, Z. J., Chen, L. L., & Xu, Z. (2021). Research achievements of oral submucous fibrosis: Progress and prospect. BioMed Research International, 2021, Article 6631856. https://doi.org/10.1155/2021/6631856
  3. Rao, N. R., Villa, A., More, C. B., Jayasinghe, R. D., Kerr, A. R., & Johnson, N. W. (2020). Oral submucous fibrosis: A contemporary narrative review with a proposed inter-professional approach for early diagnosis and clinical management. Journal of Otolaryngology - Head & Neck Surgery, 49(1), 3. https://doi.org/10.1186/s40463-019-0398-5
  4. Arakeri, G., & Brennan, P. A. (2013). Oral submucous fibrosis: An overview of the aetiology, pathogenesis, classification, and principles of management. British Journal of Oral and Maxillofacial Surgery, 51(7), 587–593. https://doi.org/10.1016/j.bjoms.2012.08.014
  5. Hazare, V. K., Goel, R. R., & Gupta, P. C. (1998). Oral submucous fibrosis, areca nut and pan masala use: A case-control study. National Medical Journal of India, 11(6), 299–300.
  6. Lin, F., Xiao, T., Wang, B., Wang, L., Liu, G., Wang, R., Xie, C., & Tang, Z. (2024). Mechanisms and markers of malignant transformation of oral submucous fibrosis. Heliyon, 10(1), e23314. https://doi.org/10.1016/j.heliyon.2023.e23314
  7. Warnakulasuriya, S., et al. (2021). Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification. Oral Diseases, 27(8), 1862–1880. https://doi.org/10.1111/odi.13704
  8. Warnakulasuriya, S., et al. (2022). Areca nut and oral cancer: Evidence from studies conducted in humans. Journal of Dental Research, 101(10), 1139–1146. https://doi.org/10.1177/00220345221091568
  9. Kujan, O., Mello, F. W., & Warnakulasuriya, S. (2021). Malignant transformation of oral submucous fibrosis: A systematic review and meta-analysis. Oral Diseases, 27(8), 1936–1946. https://doi.org/10.1111/odi.13727
  10. You, J. R., Chen, Y. T., Hsieh, C. Y., Chen, S. Y., Lin, T. Y., Shih, J. S., Chen, G. T., Feng, S. W., Peng, T. Y., & Lee, I. T. (2023). Exploring possible diagnostic precancerous biomarkers for oral submucous fibrosis: A narrative review. Cancers, 15(19), 4812. https://doi.org/10.3390/cancers15194812
  11. Zhou, S., Zhu, Y., Mashrah, M., Zhang, X., He, Z., Yao, Z., Zhang, C., Guo, F., Hu, Y., & Zhang, C. (2017). Expression pattern of DKK3 in the malignant progression of oral submucous fibrosis. Oncology Reports, 37(2), 979–985. https://doi.org/10.3892/or.2016.5317
  12. Surboyo, M. D. C., Merdietio Boedi, R., Mahdani, F. Y., Ayuningtyas, N. F., Shalgm, B., Paramananda, D. B., & Indriyani, I. (2024). Alteration of salivary biomarkers in oral submucous fibrosis: A three-level meta-analysis study. Clinical Biochemistry, 130, 110790. https://doi.org/10.1016/j.clinbiochem.2024.110790
  13. Naik, V., Kumar, M., Solomon, M. C., Chandrashekhar, C., & Guddattu, V. (2025). Clinical and histological indicators for malignant transformation of oral submucous fibrosis. BMC Oral Health, 25(1), 1053. https://doi.org/10.1186/s12903-025-04606-1
  14. Hazarey, V. K., Erlewad, D. M., Mundhe, K. A., & Ughade, S. N. (2007). Oral submucous fibrosis: Study of 1000 cases from central India. Journal of Oral Pathology & Medicine, 36(1), 12–17. https://doi.org/10.1111/j.1600-0714.2006.00462.x
  15. Jian, X. C., Peng, J. Y., Tang, Z. G., Shen, Q., & Su, T. (2000). Three cases of oral cancer associated with oral submucous fibrosis. Journal of Clinical Stomatology, 18, 130–131.
  16. Bohra, A., Maheswari, T. N. U., & Harsh, A. (2025). Artificial intelligence innovations in understanding oral submucous fibrosis: A systematic review. Asian Pacific Journal of Cancer Prevention, 26(11), 3925–3930.
  17. Dinesh, Y., Ramalingam, K., Ramani, P., & Mohan Deepak, R. (2023). Machine learning in the detection of oral lesions with clinical intraoral images. Cureus, 15(8), e44018. https://doi.org/10.7759/cureus.44018
  18. Chaudhary, N., Rai, A., Rao, A. M., Faizan, M. I., Augustine, J., Chaurasia, A., et al. (2024). High-resolution AI image dataset for diagnosing oral submucous fibrosis and squamous cell carcinoma. Scientific Data, 11(1), 1050. https://doi.org/10.1038/s41597-024-03659-4

Looking up citing articles…